Medrobotics® Closes $20MM Financing To Expand Into General Surgery And Build Next Generation Robot System
21 Februar 2017 - 6:01AM
Business Wire
Development of Multiple New Surgical Applications and Next
Generation Robotic System to Fuel Future Growth of Company’s
Flex® Surgical Platform
Medrobotics Corp., a medical products company, today announced
closing a $20 Million Preferred Stock financing. Existing
Medrobotics shareholders participated in the round. Proceeds will
be used to fund the Company’s expansion into new surgical
applications, such as single-port general and gynecological
surgeries, and to develop its next generation Flex® Robotic System
with more fully robotic instrument options.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20170220005705/en/
Medrobotics® has raised $20 Million to
fund advances in its surgical robotic technology. (Photo: Business
Wire)
Medrobotics will continue to pursue scarless ENT, colorectal and
gynecological procedures to be performed through natural body
orifices with the world’s first and only commercially released
steerable and shapeable robotic surgical products. Additionally,
the Company will develop the Flex® Robotic System for single port
abdominal applications for a variety of difficult to reach
procedures in general surgery, urology, and gynecology.
The Flex® Robotic System has been cleared for ENT procedures in
the United States and internationally. Last year, Medrobotics
became the first robotic company to obtain regulatory clearance for
minimally invasive, flexible robotic products for colorectal
procedures in Europe and Asia. The Flex® Robotic System is now the
first robotic surgical platform offering the ability to access hard
to reach anatomy in both otolaryngology and colorectal procedures
without the limits imposed by straight rigid instruments.
About MedroboticsMedrobotics Corporation
(www.Medrobotics.com) is a privately funded medical device company
headquartered in Raynham, Massachusetts. The Company manufactures
and markets the Flex® Robotic System, the world’s first robotic
surgical platform with a steerable and shapeable robotic scope. The
Flex® Robotic System offers surgeons the unique ability to navigate
complex anatomy minimally invasively and operate in hard-to-reach
anatomical locations that might otherwise be inaccessible with
straight, rigid surgical tools. The Company’s is committed to
providing more patients access to advanced, minimally invasive
surgery. Medrobotics received FDA clearance for the Flex® Robotic
System in July 2015, and the CE mark in March 2014. The System is
not yet cleared for colorectal applications in the US.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170220005705/en/
Medrobotics CorporationKevin Knight, 214-732-9392